Literature DB >> 17244851

The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index.

Jennifer S Labus1, Emeran A Mayer, Lin Chang, Roger Bolus, Bruce D Naliboff.   

Abstract

OBJECTIVES: The Visceral Sensitivity Index (VSI) was developed as the first instrument to assess gastrointestinal-specific anxiety, the cognitive, affective, and behavioral response to fear of gastrointestinal sensations, symptoms, and the context in which these visceral sensations and symptoms occur. The purpose of the current study was to a) replicate the previously reported psychometric properties of the VSI, b) assess the known-groups and concurrent validity of the instrument, and c) test conceptual hypotheses regarding gastrointestinal-specific anxiety in comparison to other general measures of psychological distress as a crucial mechanism (mediator/moderator) underlying irritable bowel syndrome diagnosis and its symptoms.
METHODS: Two undergraduate student samples (n > 500) were administered the VSI along with measures assessing presence of lower gastrointestinal symptoms, nongastrointestinal pain, health-service utilization, anxiety, depression, vitality, neuroticism, and anxiety sensitivity. Path analyses tested the hypothesis that gastrointestinal-specific anxiety mediates the relationship between affective variables and irritable bowel syndrome diagnosis and symptoms. A 'known-groups' validity approach elucidated the relevance of gastrointestinal-specific anxiety across a spectrum of irritable bowel syndrome patients.
RESULTS: Good concurrent, divergent and discriminant validity was demonstrated. Logistic regression revealed that gastrointestinal-specific anxiety is the key explanatory variable of irritable bowel syndrome diagnostic status. Path analysis demonstrated that gastrointestinal-specific anxiety mediates the relationship between general psychological distress measures and gastrointestinal symptom severity. The VSI was related to gastrointestinal, but not nongastrointestinal, symptom severity.
CONCLUSIONS: Overall, the VSI demonstrated excellent psychometric properties providing further support for its use in mechanistic studies of the role of anxiety in irritable bowel syndrome presentation.

Entities:  

Mesh:

Year:  2007        PMID: 17244851     DOI: 10.1097/PSY.0b013e31802e2f24

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  70 in total

1.  Brain networks underlying perceptual habituation to repeated aversive visceral stimuli in patients with irritable bowel syndrome.

Authors:  Jennifer S Labus; Bruce D Naliboff; Steve M Berman; Brandall Suyenobu; Eduardo P Vianna; Kirsten Tillisch; Emeran A Mayer
Journal:  Neuroimage       Date:  2009-06-06       Impact factor: 6.556

Review 2.  Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database.

Authors:  Puja Khanna; Nikhil Agarwal; Dinesh Khanna; Ron D Hays; Lin Chang; Roger Bolus; Gil Melmed; Cynthia B Whitman; Robert M Kaplan; Rikke Ogawa; Bradley Snyder; Brennan Mr Spiegel
Journal:  Am J Gastroenterol       Date:  2013-12-17       Impact factor: 10.864

3.  Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report.

Authors:  Brennan Spiegel; Michael Camilleri; Roger Bolus; Viola Andresen; William D Chey; Sheri Fehnel; Allen Mangel; Nicholas J Talley; William E Whitehead
Journal:  Gastroenterology       Date:  2009-08-23       Impact factor: 22.682

4.  Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome.

Authors:  Kate Wolitzky-Taylor; Michelle G Craske; Jennifer S Labus; Emeran A Mayer; Bruce D Naliboff
Journal:  Behav Res Ther       Date:  2012-06-23

5.  Understanding gastrointestinal distress: a framework for clinical practice.

Authors:  Brennan M R Spiegel; Dinesh Khanna; Roger Bolus; Nikhil Agarwal; Puja Khanna; Lin Chang
Journal:  Am J Gastroenterol       Date:  2011-03       Impact factor: 10.864

6.  Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome.

Authors:  A Patel; S Hasak; B Cassell; M A Ciorba; E E Vivio; M Kumar; C Prakash Gyawali; G S Sayuk
Journal:  Aliment Pharmacol Ther       Date:  2016-05-30       Impact factor: 8.171

7.  A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations.

Authors:  Michelle G Craske; Kate B Wolitzky-Taylor; Jennifer Labus; Stephen Wu; Michael Frese; Emeran A Mayer; Bruce D Naliboff
Journal:  Behav Res Ther       Date:  2011-04-19

8.  GERD symptoms in the general population: prevalence and severity versus care-seeking patients.

Authors:  Erica Cohen; Roger Bolus; Dinesh Khanna; Ron D Hays; Lin Chang; Gil Y Melmed; Puja Khanna; Brennan Spiegel
Journal:  Dig Dis Sci       Date:  2014-05-09       Impact factor: 3.199

9.  Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis.

Authors:  J S Labus; B N Naliboff; J Fallon; S M Berman; B Suyenobu; J A Bueller; M Mandelkern; E A Mayer
Journal:  Neuroimage       Date:  2008-03-20       Impact factor: 6.556

10.  Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat.

Authors:  Christian Twiss; Lisa Kilpatrick; Michelle Craske; C A Tony Buffington; Edward Ornitz; Larissa V Rodríguez; Emeran A Mayer; Bruce D Naliboff
Journal:  J Urol       Date:  2009-03-14       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.